Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine
|
May 6, 2019
Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia
Tzu-Yin Lin, Yanjun Zhu, Yuanpei Li, et al.
Cancer Immunology, Immunotherapy : CII
|
June 8, 2020
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer
Qilai Long, Ai-Hong Ma, Hongyong Zhang, et al.
The Prostate
|
June 4, 2004
Molecular alterations associated with LNCaP cell progression to androgen independence
Xu-Bao Shi, Ai-Hong Ma, Clifford G Tepper, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 7, 2007
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
Xu-Bao Shi, Lingru Xue, Joy Yang, et al.
Scientific Reports
|
September 27, 2017
Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells
Pantea Gheibi, Shuxiong Zeng, Kyung Jin Son, et al.
Biochemical and Biophysical Research Communications
|
July 16, 2019
Fidelity of a PDX-CR model for bladder cancer
Abdul M Mondal, Ai-Hong Ma, Guangzhao Li, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
January 11, 2018
Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model
Qilai Long, Tzu-Yin Lin, Yee Huang, et al.
Molecular Pharmacology
|
August 18, 2012
Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs
Wenchang Guo, Ruiwu Liu, Yoko Ono, et al.
Cancer Letters
|
February 7, 2021
Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis
Kimberley Katleba, Alan P Lombard, Maria-Malvina Tsamouri, et al.
EJNMMI Research
|
February 29, 2016
Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors
Wenwu Xiao, Tianhong Li, Fernanda C Bononi, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Nanomedicine : Nanotechnology, Biology, and Medicine
|
May 6, 2019
Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia
Tzu-Yin Lin, Yanjun Zhu, Yuanpei Li, et al.
Cancer Immunology, Immunotherapy : CII
|
June 8, 2020
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer
Qilai Long, Ai-Hong Ma, Hongyong Zhang, et al.
The Prostate
|
June 4, 2004
Molecular alterations associated with LNCaP cell progression to androgen independence
Xu-Bao Shi, Ai-Hong Ma, Clifford G Tepper, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 7, 2007
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
Xu-Bao Shi, Lingru Xue, Joy Yang, et al.
Scientific Reports
|
September 27, 2017
Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells
Pantea Gheibi, Shuxiong Zeng, Kyung Jin Son, et al.
Biochemical and Biophysical Research Communications
|
July 16, 2019
Fidelity of a PDX-CR model for bladder cancer
Abdul M Mondal, Ai-Hong Ma, Guangzhao Li, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
January 11, 2018
Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model
Qilai Long, Tzu-Yin Lin, Yee Huang, et al.
Molecular Pharmacology
|
August 18, 2012
Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs
Wenchang Guo, Ruiwu Liu, Yoko Ono, et al.
Cancer Letters
|
February 7, 2021
Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis
Kimberley Katleba, Alan P Lombard, Maria-Malvina Tsamouri, et al.
EJNMMI Research
|
February 29, 2016
Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors
Wenwu Xiao, Tianhong Li, Fernanda C Bononi, et al.
Page
of 4